Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: Molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridization

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Nishio, Jun ^a   Iwasaki, Hiroshi ^a   Nabeshima, Kazuki ^a   Ishiguro, Masako ^a   Isayama, Teruto ^b   Naito, Masatoshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Yanagawa Rehabilitation Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIMENTIN;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE FU MFH 2; CELL NUCLEUS; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 15Q; CHROMOSOME 16P; CHROMOSOME 17; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 20; CHROMOSOME 2Q; CHROMOSOME 3P; CHROMOSOME 4P; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME BAND; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR CELLS AND CELL LINES; X CHROMOSOME; ANIMAL; DRUG SCREENING; GENETICS; MOUSE MUTANT; PATHOLOGY; TUMOR CELL LINE;

AGED; ANIMALS; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICE, SCID; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 78549246582     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-153     Document Type: Article

References (37)

1. Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. CDM Fletcher E van den Berg WM Molenaar, WHO Classification of Tumours, Pathology and Genetics of Tumours of Soft Tissue and Bone IARC Press: Lyon, France, Fletcher CDM, Unni KK, Mertens F, 2002 120 122
2. Establishment and characterization of neoplastic cells from a malignant fibrous histiocytoma. A possible stem cell line. K Shirasuna M Sugiyama T Miyazaki, Cancer 1985 55 2521 2532 10.1002/1097-0142(19850601)55:11<2521:: AID-CNCR2820551102>3.0.CO;2-L 2986815
3. Characterization of two cell lines, derived from two malignant fibrous histiocytomas. PJ Roholl J Kleyne M Van Blokland PL Spies DH Rutgers CE Albus-Lutter JA Van Unnik, J Pathol 1986 150 103 112 10.1002/path.1711500204 3025391
4. Biological behavior of cloned cells of human malignant fibrous histiocytoma in vivo and in vitro. T Kanzaki S Kitajima K Suzumori, Cancer Res 1991 51 2133 2137 1849043
5. Malignant fibrous histiocytoma: a tumor of facultative showing mesenchymal differentiation in culture cell lines. H Iwasaki T Isayama Y Ohjimi M Kikuchi S Yoh N Shinohara K Yoshitake M Ishiguro N Kamada M Enjoji, Cancer 1992 69 437 447 10.1002/1097-0142(19920115)69:2<437::AID-CNCR2820690227>3. 0.CO;2-U 1309433
6. Establishment and characterization of a human malignant fibrous histiocytoma cell line. T Yonemoto T Takenouchi H Tokita S Tatezaki N Mukaida A Mikata H Moriya, Clin Orthop Relat Res 1995 320 159 167 7586821
7. Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931. AK Krause SH Hinrichs C Orndal J DeBoer JR Neff JA Bridge, Cancer Genet Cytogenet 1997 94 138 143 10.1016/S0165-4608(96)00223-3 9109944
8. Wild-type p53 gene transfer resulted in cell cycle arrest, but not apoptosis of newly established human malignant fibrous histiocytoma cell line. K Endo T Sakatani M Watanabe H Yoshida E Nanba H Ito, Int J Oncol 1999 15 935 942 10536176
9. A novel human malignant fibrous histiocytoma cell line of the heart (MFH-H) with secretion of hematopoietic growth factor. P Reinecke R Moll B Hildebrandt M Schmitz EM Schneider P Koldovsky C Schardt HE Gabbert C Gerharz, Anticancer Res 1999 19 1901 1907 10470134
10. Establishment of a human malignant fibrous histiocytoma cell line, COMA: characterization by conventional cytogenetics, comparative genomic hybridization, and multiflex fluorescence in situ hybridization. A Mairal F Chibon A Rousselet J Couturier P Terrier A Aurias, Cancer Genet Cytogenet 2000 121 117 123 10.1016/S0165-4608(00)00261-2 11063793
11. Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus. Y Kiyozuka H Nakagawa Y Uemura H Senzaki A Yamamoto T Noguchi H Mizuta K Nakanishi S Nakano A Tsubura, Cancer Genet Cytogenet 2001 27 7 15 10.1016/S0165-4608(00)00413-1 (Pubitemid 32530087)
12. Characterization of four cell lines derived from a human malignant fibrous histiocytoma of the maxillary sinus. A Mori T Tagawa T Kamei T Murata M Inui S Ohse, Oral Oncol 2001 37 527 536 10.1016/S1368-8375(01)00004-5 11435180
13. Establishment and characterization of cell line TNMY1 derived from human malignant fibrous histiocytoma. T Nakatani T Marui T Yamamoto M Kurosaka T Akisue K Matsumoto, Pathol Int 2001 51 595 602 10.1046/j.1440-1827.2001.01253.x 11564213
14. Establishment and characterization of a cell line from a malignant fibrous histiocytoma of bone developing in a patient with multiple fibrous dysplasia. Z Fang H Mukai K Nomura K Shinomiya S Matsumoto N Kawaguchi T Kitagawa H Kanda, J Cancer Res Clin Oncol 2002 128 45 49 10.1007/s00432-001- 0295-0 11862471
15. Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization. J Nishio H Iwasaki M Ishiguro Y Ohjimi N Nishimura T Koga T Kawarabayashi Y Kaneko M Kikuchi, Cancer Genet Cytogenet 2003 144 44 51 10.1016/S0165-4608(02)00925-1 12810255
16. Establishment and characterization of a novel myxofibrosarcoma cell line. H Kawashima A Ogose W Gu J Nishio N Kudo N Kondo T Hotta H Umezu T Tohyama H Nishijima H Iwasaki N Endo, Cancer Genet Cytogenet 2005 161 28 35 10.1016/j.cancergencyto.2005.02.003 16080955 (Pubitemid 41096048)
17. Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2. M Hakozaki H Hojo M Sato T Tajino H Yamada S Kikuchi M Abe, Anticancer Res 2006 26 3393 3402 17094458
18. ISCN. An international system for human cytogenetic nomenclature. LG Shaffer ML Slovak LJ Campbell, Basel: Karger 2009
19. A cyotogetic analyses in two cases of malignant peripheral nerve sheath tumor showing hypodiploid karyotype. M Ishiguro H Iwasaki M Takeshita Y Hirose Y Kaneko, Oncol Rep 2006 16 225 232 16820897
20. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. J Nishio PA Althof JM Bailey M Zhou JR Neff FG Barr DM Parham L Teot SJ Qualman JA Bridge, Lab Invest 2006 86 547 556 16607381
21. Overrepresentation of 17q22-qter and 22q13 in dermatofibrosarcoma protuberans but not in dermatofibroma: a comparative genomic hybridization study. J Nishio H Iwasaki Y Ohjimi M Ishiguro T Isayama M Naito A Iwashita M Kikuchi, Cancer Genet Cytogenet 2002 132 102 108 10.1016/S0165-4608(01)00546-5 11850069
22. Pathology of soft-tissue tumors: daily diagnosis, molecular cytogenetics and experimental approach. H Iwasaki K Nabeshima J Nishio S Jimi M Aoki K Koga M Hamasaki H Hayashi A Mogi, Pathol Int 2009 59 501 521 10.1111/j.1440-1827.2009. 02401.x 19627534
23. Malignant fibrous histiocytoma with a 19p+ marker chromosome have increased relapse rate. A Rydholm N Mandahl S Heim A Kreicbergs H Willen F Mitelman, Genes Chromosomes Cancer 1990 2 296 299 10.1002/gcc.2870020407 2176542
24. 19p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. PFM Choong N Mandahl F Mertens H Willen T Alvegard A Kreicbergs F Mitelman A Rydholm, Genes Chromosomes Cancer 1996 16 88 93 10.1002/(SICI)1098- 2264(199606)16:2<88::AID-GCC2>3.0.CO;2-Z 8818655
25. Cytogenetic characterization of ten malignant fibrous histiocytomas. H Schmidt S Körber R Hinze H Taubert A Meye P Würl HJ Holzhausen H Dralle FW Rath, Cancer Genet Cytogenet 1998 100 134 142 10.1016/S0165-4608(97) 00019-8 9428357
26. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. ML Larramendy M Tarkkanen C Blomqvist M Virolainen T Wiklund S Asko-Seljavaara I Elomaa S Knuutila, Am J Pathol 1997 151 1153 1161 9327749
27. Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas. A comparative genomic hybridization analysis of a series of 30 cases. A Mairal P Terrier F Chibon X Sastre A Lecesne A Aurias, Cancer Genet Cytogenet 1999 111 134 138 10.1016/S0165-4608(98)00227-1 10347550
28. Assessment of genomic imbalances in malignant fibrous histiocytomas by comparative genomic hybridization. R Hinze U Schagdarsurengin H Taubert A Meye P Wurl HJ Holzhausen FW Rath H Schmidt, Int J Mol Med 1999 3 75 79 9864389
29. Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis. WH Weng J Ahlen WO Lui O Brosjo ST Pang A Von Rosen G Auer O Larsson C Larsson, Br J Cancer 2003 89 720 726 10.1038/sj.bjc.6601069 12915885
30. Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin? A Carneiro P Francis PO Bendahl J Fernebro M Akerman C Fletcher A Rydholm A Borg M Nilbert, Lab Invset 2009 89 668 675 10.1038/labinvest.2009.18
31. Malignant fibrous histiocytoma of bone: analysis of genomic imbalance by comparative genomic hybridization and C-MYC expression by immunohistochemistry. M Tarkkanen ML Larramendy T Bohling M Serra CM Hattinger A Kivioja I Elomaa P Picci S Knuutila, Eur J Cancer 2006 42 1172 1180 10.1016/j.ejca.2006.01.035 16630715
32. Array comparative genomic hybridization analysis of uterine leiomyosarcoma. YL Cho S Bae MS Koo KM Kim HJ Chun CK Kim DY Ro JH Kim CH Lee YW Kim WS Ahn, Gynecol Oncol 2005 99 545 551 10.1016/j.ygyno.2005.07.017 16125217
33. Notch signaling. S Artavanis-Tsakonas K Matsuno ME Fortini, Science 1995 268 225 232 10.1126/science.7716513 7716513
34. Notch signaling contributes to the pathogenesis of human osteosarcomas. F Engin T Bertin O Ma MM Jiang L Wang RE Sutton LA Donehower B Lee, Hum Mol Genet 2009 18 1464 1470 10.1093/hmg/ddp057 19228774
35. Tenascin expression in cutaneous fibrohistiocytic tumors. Immunohistochemical investigation of 24 cases. A Franchi M Santucci, Am J Dermatopathol 1996 18 454 459 10.1097/00000372-199610000-00002 8902090
36. The regulation of INK4/ARF in cancer and aging. WY Kim NE Sharpless, Cell 2006 127 265 275 10.1016/j.cell.2006.10.003 17055429
37. INK4A) and other genomic imbalances in human malignant fibrous histiocytoma. A Simons M Schepens J Jeuken S Sprenger G van de Zande B Bjerkehagen A Forus V Weibolt I Molenaar E van de Berg O Myklebost J Bridge AG van Kessel R Suijkerbuijk, Cancer Genet Cytogenet 2000 118 89 98 10.1016/S0165-4608(99)00178-8 10748288